Cargando…
The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
The use of vaccines has allowed the containment of coronavirus disease 2019 (COVID-19) at a global level. The present work aims to add data on vaccination by evaluating the level of neutralizing antibodies in individuals who have received a three-vaccination series. For this purpose, we ran a survei...
Autores principales: | Nicolai, Eleonora, Tomassetti, Flaminia, Pelagalli, Martina, Sarubbi, Serena, Minieri, Marilena, Nisini, Alberto, Nuccetelli, Marzia, Ciotti, Marco, Pieri, Massimo, Bernardini, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604657/ https://www.ncbi.nlm.nih.gov/pubmed/37893035 http://dx.doi.org/10.3390/biomedicines11102661 |
Ejemplares similares
-
Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022) -
Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022) -
Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021) -
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022) -
Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels
por: Nicolai, Eleonora, et al.
Publicado: (2023)